اخبار و اعلانات

 آمار

تعداد نشریات286
تعداد نشریات سازمان84
تعداد شماره‌ها3,029
تعداد مقالات33,888
تعداد مشاهده مقاله45,264,309
تعداد دریافت فایل اصل مقاله60,945,034
Jethani, Varuna, Khanduri, Rakhee, Jethani, Sumit, Singh, Sunil, Shrivastava, A K, Kotwal, Aarti, Goyal, Mamta. (1404). Prevalence of tuberculosis/COVID 19 co-infection among active tuberculosis patients at a tertiary care hospital in Uttarakhand, India. سامانه مدیریت نشریات علمی, 80(3), 675-681. doi: 10.32592/ARI.2025.80.3.675
Varuna Jethani; Rakhee Khanduri; Sumit Jethani; Sunil Kumar Singh; A K Shrivastava; Aarti Kotwal; Mamta Goyal. "Prevalence of tuberculosis/COVID 19 co-infection among active tuberculosis patients at a tertiary care hospital in Uttarakhand, India". سامانه مدیریت نشریات علمی, 80, 3, 1404, 675-681. doi: 10.32592/ARI.2025.80.3.675
Jethani, Varuna, Khanduri, Rakhee, Jethani, Sumit, Singh, Sunil, Shrivastava, A K, Kotwal, Aarti, Goyal, Mamta. (1404). 'Prevalence of tuberculosis/COVID 19 co-infection among active tuberculosis patients at a tertiary care hospital in Uttarakhand, India', سامانه مدیریت نشریات علمی, 80(3), pp. 675-681. doi: 10.32592/ARI.2025.80.3.675
Jethani, Varuna, Khanduri, Rakhee, Jethani, Sumit, Singh, Sunil, Shrivastava, A K, Kotwal, Aarti, Goyal, Mamta. Prevalence of tuberculosis/COVID 19 co-infection among active tuberculosis patients at a tertiary care hospital in Uttarakhand, India. سامانه مدیریت نشریات علمی, 1404; 80(3): 675-681. doi: 10.32592/ARI.2025.80.3.675

Prevalence of tuberculosis/COVID 19 co-infection among active tuberculosis patients at a tertiary care hospital in Uttarakhand, India

Archives of Razi Institute
مقاله 16، دوره 80، شماره 3، مرداد و شهریور 2025، صفحه 675-681    اصل مقاله (459.73 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.32592/ARI.2025.80.3.675
نویسندگان
Varuna Jethani1؛ Rakhee Khanduri1؛ Sumit Jethani2؛ Sunil Kumar Singh* 3؛ A K Shrivastava4؛ Aarti Kotwal5؛ Mamta Goyal6
1Department of Respiratory Medicine,HIMS,Dehradun
2Department of Community Medicine, North DMC Medical College & Hindu Rao Hospital, New Delhi
3Department of Community Medicine, Shri Atal Bihari Vajpayee Government Medical College, Chhainsa, Faridabad
4Department of community medicine ,HIMS, Dehradun
5Department of microbiology, HIMS, Dehradun
6Department of Radiodiagnosis, HIMS, Dehradun
چکیده
Coronavirus disease 2019 (COVID-19) was spread all over the world and was accepted as a pandemic by the World Health Organization (WHO) on March 11, 2020. Lungs are predominantly affected by tuberculosis and Covid-19. The objective of the study was to assess the clinical features of COVID-19 in active tuberculosis (pulmonary and extra-pulmonary) and to identify the radiological and laboratory picture of COVID 19 in patients with active tuberculosis. A cross sectional study was by the Department of Respiratory Medicine, Himalayan Institute of Medical Sciences, among patients of active tuberculosis (pulmonary and extra-pulmonary) presented to the General Outpatient Department(OPD) of the Respiratory Medicine Department. The questionnaire included questions on socio demographic profile, clinical features, comorbidities, clinical history, any substance abuse and laboratory investigations. Data was analyzed by SPSS software version 21.0 while Chi- square test was used for categorical data analysis. The mean age of the study participants was 47.5±5.3 years (Range 18-72). Males constituted the larger group (59.38%) as compared to females (40.63%). The prevalence of COVID19/tuberculosis co-infection in the present study was 21.8%. Positive history of contact, bacterial culture, PCR and CBNAAT, use of drug, presence of cavity and pleural effusion on X Ray, showed all remarkably higher chances (p< 0.05) of developing co-infection. The prevalence of COVID19/tuberculosis co-infection in the present study was high. Significantly associated factors can help in identifying Covid 19 infection among tuberculosis patients. Therefore, it is recommended that screening for these factors should be done for all the tuberculosis patients coming for treatment and Covid 19 vaccination.
کلیدواژه‌ها
Lung؛ Xray؛ Pleural effusion؛ history؛ addiction
مراجع
  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine. 2020;382(13):1199-207.
  2. Organization WH. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance, 17 January 2020: World Health Organization; 2020.
  3. Jeyashree K, Thangaraj J, Rade K, Modi B, Selvaraju S, Velusamy S, et al. Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015–2020. BMJ open. 2022;12(7):e060197.
  4. Chadha VK. Tuberculosis epidemiology in India: a review. The international journal of tuberculosis and lung disease. 2005;9(10):1072-82.
  5. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, et al. An interferon‐γ‐related cytokine storm in SARS patients. Journal of medical virology. 2005;75(2):185-94.
  6. Chen Y, Wang Y, Fleming J, Yu Y, Gu Y, Liu C, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv. 2020:2020.03. 10.20033795.
  7. Mangamba L-ME, Sike CIM, Tochie JN, Dalle GN, Nkouagmi N, Balkissou AD, et al. Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study. Pan African Medical Journal. 2023;44(1).
  8. Nuwagira E, Mpagama SG, Katusiime A, Natamba B, Baluku JB, Lai PS. Coinfection of COVID-19 and Tuberculosis in Uganda. The American Journal of Tropical Medicine and Hygiene. 2023;108(6):1240.
  9. Boushab B, Savadogo M, Sow M. Prevalence of smear-positive pulmonary tuberculosis in Aïoun hospital (Hodh El Garbi). Revue de pneumologie clinique. 2015;72(4):243-7.
  10. Chen Q, Zheng Z, Zhang C, Zhang X, Wu H, Wang J, et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020;48(4):543-51.
  11. Tékpa G, Fikouma V, Téngothi RMM, Longo JdD, Woyengba APA, Koffi B. Epidemiological and clinical features of tuberculosis at the Hôpital de l'Amitié in Bangui. The Pan African Medical Journal. 2019;33:31-.
  12. Gupta N, Ish P, Gupta A, Malhotra N, Caminero JA, Singla R, et al. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis. European Respiratory Journal. 2020;56(5).
  13. Kunst H, Burman M, Arnesen T, Fiebig L, Hergens M, Kalkouni O, et al. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results. The International Journal of Tuberculosis and Lung Disease. 2017;21(8):840-51.
  14. Hazra D, Siddalingaiah N, Gupta N, Chawla K, Prabhu AR, Datta D, et al. COVID-19 and tuberculosis coinfection: A case–control study from a tertiary care center in South India. Journal of Family Medicine and Primary Care. 2023;12(12):3200-3.
  15. Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. European Respiratory Journal. 2020;56(1).
  16. Tadolini M, Codecasa LR, García-García J-M, Blanc F-X, Borisov S, Alffenaar J-W, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. European Respiratory Journal. 2020.
آمار
تعداد مشاهده مقاله: 146
تعداد دریافت فایل اصل مقاله: 157


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب